INDEX VALUES   |

Home > Our Indexes > LSCIBC

Download Methodology

LifeSci Biotechnology Clinical Trials Index


The LifeSci Biotechnology Clinical Trials Index ("LSCIBC") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The inception date for LSCIBC was November 3, 2014.

LSCIBCS&P 500
Prior Day Closing Value4498.684771.02
Prior Day Change %-0.91%-0.59%
Current Value
Current Day Change %-1.82%+1.51%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Sep 22, 2017)


No. of Constituents 74
Total Market Cap ($ in millions) 0
Mean Market Cap ($ in millions) 0
Median Market Cap ($ in millions) 0
Largest Constituent ($ in millions) 0
Smallest Constituent ($ in millions) 0

Market Cap Breakdown (Sep 22, 2017)


Top 10 Constituents (Sep 22, 2017)


Constituent Ticker Weight
Myokardia Inc MYOK 3.46%
Dynavax Technologies Corp DVAX 2.80%
Beigene Ltd-adr BGNE 2.30%
Kite Pharma Inc KITE 2.14%
Juno Therapeutics Inc JUNO 2.09%
Arena Pharmaceuticals Inc ARNA 1.99%
Sangamo Therapeutics Inc SGMO 1.97%
Insmed Inc INSM 1.93%
Intra-cellular Therapies Inc ITCI 1.92%
Fibrogen Inc FGEN 1.88%
Data Updated Daily
Download All Constituents